LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - ProPhase Labs (NASDAQ: PRPH)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
03/17/2024
Buy
$6.00
400,000
$2.400M
400,000
NASDAQ PRPH ProPhase Labs
Latkin Jed / director
01/01/2024
Buy
$6.00
500,000
$3.000M
500,000
NASDAQ PRPH ProPhase Labs
Hirsch Warren / director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ PRPH ProPhase Labs
GLECKEL LOUIS MD / director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ PRPH ProPhase Labs
Barr Jason Michael / director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
03/17/2024
Sell
$6.00
400,000
$2.400M
400,000
NASDAQ PRPH ProPhase Labs
Hirsch Warren / director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
GLECKEL LOUIS MD / director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
Barr Jason Michael / director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
Hirsch Warren / director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
Barr Jason Michael / director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
GLECKEL LOUIS MD / director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ PRPH ProPhase Labs
Morse Robert A. Jr. / officer: CHIEF FINANCIAL OFFICER
04/04/2023
Buy
$9.00
50,000
$450K
50,000
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
04/03/2023
Buy
$9.00
500,000
$4.500M
500,000
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Buy
$0.60
500,000
$300K
3.85M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Sell
$8.18
268,337
$2.195M
3.58M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Sell
$0.60
500,000
$300K
0
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
01/13/2023
Buy
$0.60
600,000
$360K
3.67M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
01/13/2023
Sell
$9.36
319,231
$2.988M
3.35M
NASDAQ PRPH ProPhase Labs
Morse Robert A. Jr. / officer: Controller
01/13/2023
Sell
$12.01
50,000
$601K
0
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
10/16/2022
Buy
$0.60
600,000
$360K
3.39M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
10/16/2022
Sell
$10.41
317,291
$3.303M
3.07M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
08/10/2022
Buy
$0.60
600,000
$360K
3.11M
NASDAQ PRPH ProPhase Labs
Karkus Ted William / officer: CEO & CHAIRMAN
08/10/2022
Sell
$10.84
316,605
$3.432M
2.79M

COPYRIGHT ©2023 HEALTH STOCKS HUB